177 related articles for article (PubMed ID: 30259654)
1. Human Serum Albumin-Based Drug-Free Macromolecular Therapeutics: Apoptosis Induction by Coiled-Coil-Mediated Cross-Linking of CD20 Antigens on Lymphoma B Cell Surface.
Zhang L; Fang Y; Li L; Yang J; Radford DC; Kopeček J
Macromol Biosci; 2018 Nov; 18(11):e1800224. PubMed ID: 30259654
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo.
Tommy Gambles M; Li J; Christopher Radford D; Sborov D; Shami P; Yang J; Kopeček J
J Control Release; 2022 Oct; 350():584-599. PubMed ID: 36037975
[TBL] [Abstract][Full Text] [Related]
3. Multimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system.
Zhang R; Yang J; Chu TW; Hartley JM; Kopeček J
Adv Healthc Mater; 2015 May; 4(7):1054-65. PubMed ID: 25612325
[TBL] [Abstract][Full Text] [Related]
4. Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.
Li L; Yang J; Wang J; Kopeček J
ACS Nano; 2018 Apr; 12(4):3658-3670. PubMed ID: 29595951
[TBL] [Abstract][Full Text] [Related]
5. Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.
Zhang L; Fang Y; Yang J; Kopeček J
J Control Release; 2017 Oct; 263():139-150. PubMed ID: 28024916
[TBL] [Abstract][Full Text] [Related]
6. Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells.
Gambles MT; Li J; Wang J; Sborov D; Yang J; Kopeček J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361811
[TBL] [Abstract][Full Text] [Related]
7. Drug-free macromolecular therapeutics exhibit amplified apoptosis in G2/M phase arrested cells.
Li L; Yang J; Wang J; Kopeček J
J Drug Target; 2019; 27(5-6):566-572. PubMed ID: 30198798
[TBL] [Abstract][Full Text] [Related]
8. Human serum albumin-based drug-free macromolecular therapeutics induce apoptosis in chronic lymphocytic leukemia patient cells by crosslinking of CD20 and/or CD38 receptors.
Li J; Gambles MT; Jones B; Williams JA; Camp NJ; Shami PJ; Yang J; Kopeček J
Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38802679
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis of human B cell lymphoma Raji cells induced by monovalent anti-CD20 antibody].
Liu YX; Fan DM; Xiong DS; Xu YF; Shao XF; Xu YS; Peng H; Yang M; Qin L; Zhu ZP; Yang CZ
Ai Zheng; 2003 Dec; 22(12):1249-53. PubMed ID: 14693045
[TBL] [Abstract][Full Text] [Related]
10. Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine.
Wang J; Li L; Yang J; Clair PM; Glenn MJ; Stephens DM; Radford DC; Kosak KM; Deininger MW; Shami PJ; Kopeček J
Nanomedicine; 2019 Feb; 16():217-225. PubMed ID: 30639670
[TBL] [Abstract][Full Text] [Related]
11. Biorecognition: A key to drug-free macromolecular therapeutics.
Yang J; Li L; Kopeček J
Biomaterials; 2019 Jan; 190-191():11-23. PubMed ID: 30391799
[TBL] [Abstract][Full Text] [Related]
12. Coiled-coil based drug-free macromolecular therapeutics: in vivo efficacy.
Wu K; Yang J; Liu J; Kopeček J
J Control Release; 2012 Jan; 157(1):126-31. PubMed ID: 21843563
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of coiled-coil based drug-free macromolecular therapeutics.
Kverka M; Hartley JM; Chu TW; Yang J; Heidchen R; Kopeček J
Biomaterials; 2014 Jul; 35(22):5886-96. PubMed ID: 24767787
[TBL] [Abstract][Full Text] [Related]
14. Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
Vega MI; Huerta-Yepez S; Martinez-Paniagua M; Martinez-Miguel B; Hernandez-Pando R; González-Bonilla CR; Chinn P; Hanna N; Hariharan K; Jazirehi AR; Bonavida B
Clin Cancer Res; 2009 Nov; 15(21):6582-94. PubMed ID: 19861448
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis.
Chu TW; Yang J; Kopeček J
Biomaterials; 2012 Oct; 33(29):7174-81. PubMed ID: 22795544
[TBL] [Abstract][Full Text] [Related]
17. Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.
Johnson RN; Kopečková P; Kopeček J
Biomacromolecules; 2012 Mar; 13(3):727-35. PubMed ID: 22288884
[TBL] [Abstract][Full Text] [Related]
18. Obinutuzumab-Based Drug-Free Macromolecular Therapeutics Synergizes with Topoisomerase Inhibitors.
Gambles MT; Sborov D; Shami P; Yang J; Kopeček J
Macromol Biosci; 2024 Mar; 24(3):e2300375. PubMed ID: 37838941
[TBL] [Abstract][Full Text] [Related]
19. Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomas.
Zhang N; Khawli LA; Hu P; Epstein AL
Clin Cancer Res; 2005 Aug; 11(16):5971-80. PubMed ID: 16115941
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.
Liu Y; Zheng M; Lai Z; Xiong D; Fan D; Xu Y; Peng H; Shao X; Xu Y; Yang M; Wang J; Liu H; Xie Y; Yang C; Zhu Z
Cancer Lett; 2004 Mar; 205(2):143-53. PubMed ID: 15036646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
